"An experimental Merck & Co. drug designed to protect infants from illness caused by respiratory syncytial virus succeeded in a late-stage trial, the company said Tuesday. In a statement, Merck said the therapy, an antibody called clesrovimab, met its main safety and efficacy objectives in a placebo-controlled trial involving more than 3,600 healthy or preterm infants."
GForce Life Sciences
Staffing and Recruiting
Chicago, Illinois 144,912 followers
We match highly targeted consultants and permanent hires to executives' needs in biotech, pharma & medical device.
About us
- Ranked #8 for Inc. 5000's Fastest Growing Companies of 2018 & #90 in 2019 - Awarded Best Places to Work in IL in 2018, 2019, 2020, 2021 & 2022 - Recognized as a Best Staffing Firm to Work For by Staffing Industry Analysts in 2018 & 2019 - Awarded Best of Staffing - Talent Satisfaction by ClearlyRated in 2019, 2020, 2021 & 2022 GForce Life Sciences matches highly targeted consultants and direct hire candidates to executives' needs. Regulatory pressures, altering market demands and healthcare refinement are changing the landscape of the global life sciences industry. Patients, providers, payers, and regulators are seeking a higher quality of care and better therapeutic benefits, along with reduced costs and enhanced transparency. With a tremendous success rate, GForce Life Sciences has worked with some of the world’s leading pharmaceutical and medical device companies to address these challenges by providing consultants and executive-level candidates to assist our clients in delivering on the promises they have made to their clients (internal and external). GForce recognizes that there is no “one-size-fits-all” approach to achieving growth and battling industry-wide challenges, therefore we begin with your specific needs and work from there to identify the consultant, team or executive that is the best fit. Unlike larger, “factory firms,” our boutique approach allows us to hand-pick and closely monitor the best candidates for your company and projects. Finally, we back our services with the industry’s leading technology infrastructure, assuring agile, transparent, personalized consulting solutions and business reporting intelligence.
- Website
-
http://www.gforcelifesciences.com
External link for GForce Life Sciences
- Industry
- Staffing and Recruiting
- Company size
- 51-200 employees
- Headquarters
- Chicago, Illinois
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Consulting, Pharmaceuticals, Medical Devices, Combination Devices, Project Management, Program Management, PMO Creation and Management, Life Sciences, Subject Matter /Technical Experts, Executive Consulting & Assessments, Project Teams, executive search, and contracting
Locations
-
Primary
35 E Wacker Dr
Suite 1200
Chicago, Illinois 60601, US
Employees at GForce Life Sciences
-
Kathy Trumpower
Client Partner @ GForce Life Sciences | Life Sciences and MedTech Connector
-
Mitch Welter
Leader with expertise in operations and supply chain who excels in company turnarounds by leveraging LSS, metrics, structure, and data driven…
-
Tyler Mills
Biotech Outsourcing + Contract Manager | CRO Finance
-
Dana Engelhardt
Self Employed at Non
Updates
-
New GForce Success Story! Follow us for more success stories and visit our website at www.gforcelifesciences.com
-
Job opportunity of the week: https://lnkd.in/g3CFq3dg
-
"A closely watched obesity pill being developed by Roche helped people in a small Phase 1 trial lose 7.3% of their body weight over four weeks when taken once daily — 6.1 percentage points more than those given a placebo, the company said Wednesday."
Obesity pill from Roche shows promising weight loss in small study
biopharmadive.com
-
New GForce Success Story! Follow us for more success stories and visit our website at www.gforcelifesciences.com
-
Job opportunity of the week: https://lnkd.in/gZ7HvAey
-
New GForce Success Story! Follow us for more success stories and visit our website at www.gforcelifesciences.com
-
“Biotechnology company HilleVax on Monday said it will halt development of an experimental norovirus vaccine in infants after the shot proved ineffective in a large trial, sending shares sliding… While development in infants is now discontinued, the Boston company said it is “exploring the potential” to continue testing HIL-214 or another candidate called HIL-216 in adults.”
HilleVax’s norovirus vaccine ineffective in large trial of infants
biopharmadive.com
-
Happy 7 year GForceaversary to the incredible Addie Ruxer!! We appreciate everything she has done and continue to be inspired by her dedication. Here's to celebrating all that you've achieved and looking forward to many more successful years ahead! 😊